Effects of Five-Year Treatment with Testosterone Undecanoate on Metabolic and Hormonal Parameters in Ageing Men with Metabolic Syndrome
Figure 2
Effects of 5-year treatment with long-acting TU on (a) systolic blood pressure (mm Hg) and (b) diastolic blood pressure (mm Hg) in 40 hypogonadal men (T < 11 nmol/L) with metabolic syndrome (IDF). variations were evaluated yearly in the testosterone treatment (TRT) versus controls (CTRL).